All News
AR882, selective uric acid transporter 1 (URAT1) inhibitor in development, completed a phase 2, 140 pt 12-week PBO controlled trial, where 75 mg/d lowered SUA by 59% (8.6 to 3.5 ) & 42% (8.6 to 5.0 ) in 50 mg dose group - all better than PBO https://t.co/HHzHWj4XQr https://t.co/gJD9hnkFJc
Links:
Dr. John Cush RheumNow ( View Tweet)
How would you treat 37yoF B27+ AS on Taltz, now pregnant?(Failed NSAIDs, TNFi's)
Dr. John Cush RheumNow ( View Tweet)
Join RheumNow Live in person or virtually on 3/18 and 3/19. This meeting is unlike any other meeting you attended.
But don't take our word for it, last year's attendees say:
"Great conference. Best in the last year. I did Hopkins, CCR, and ACR too"
https://t.co/Im6xStFwOw https://t.co/NhdbkNo1jl
Links:
Dr. John Cush RheumNow ( View Tweet)
Ferritin may be more than biomarker in Stills, etc - may contribute directly to pathogenesis. Ferritin causes PMN activation & neutrophil extracellular traps (NETs). Could this be targeted therapeutically? https://t.co/tHbS6WtNWp https://t.co/rXfqgkij7k
Dr. John Cush RheumNow ( View Tweet)
Worse Birth Outcomes in RA and SLE
A population-based retrospective cohort study patients with RA or SLE and their infants demonstrated significant adverse pregnancy outcome, particularly the infants of women with SLE.
https://t.co/oK05W8ncW0 https://t.co/3eJzHHOvXO
Links:
Dr. John Cush RheumNow ( View Tweet)
Half of all outpt. MDs are bound by restrictive covenants. FTC is considering a ban on noncompete clauses. AMA) code of ethics discourages covenants that "unreasonably restrict". FTC the rule change could save Pts up to $148 billion https://t.co/nssfbrxnLR https://t.co/8hGArfGEGW
Links:
Dr. John Cush RheumNow ( View Tweet)
173 PsA pts enrolled to start ustekinumab: half on MTX and half on PBO. At week 24 there was no difference in DAS28 between groups (2.9 vs 3.1); then Ustekinumab plus placebo was non-inferior to ustekinumab plus methotrexate https://t.co/AygtawIZsZ https://t.co/YLGp5lMWT9
Links:
Dr. John Cush RheumNow ( View Tweet)
ACP Guidelines on Fracture Prevention in at-risk Adults
The American College of Physicians (ACP) has updated its 2017 recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
https://t.co/e7qaNCXUnx https://t.co/yys4MXMyOd
Links:
Dr. John Cush RheumNow ( View Tweet)
Free great handout on DRESS - Drug Reaction With Eosinophilia and Systemic Symptoms. May affect adults or children; usually 2 to 8 weeks after beginning a medication. ~1 in 1000 taking specific drugs get DRESS. Allopurinol is a common cause https://t.co/gTW8D3raHV https://t.co/aQbnFS3rNR
Links:
Dr. John Cush RheumNow ( View Tweet)
anti-mitochondrial antibodies (AMA) in were assayed in 404 #RA patients & found to positive in 14-26%. Importantly AMA Abs were associated with erosive disease (p<0.05) and interstitial lung disease (p<0.01), independent of CCP or RF https://t.co/TW2xsa1igt https://t.co/jr1ltgGmdF
Links:
Dr. John Cush RheumNow ( View Tweet)
AutoAb analysis of 140 systemic sclerosis shows low sensitivity (<33%), high specificity (>88%). Scl-70+ signif assoc w sine scleroderma, digital ulcers, Raynauds as 1st onset sign. SSc-ILD more common Scl-70 and PAH with CENP A/B Abs https://t.co/ZQksWVauMZ https://t.co/RKSWOItdxu
Links:
Dr. John Cush RheumNow ( View Tweet)
Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update https://t.co/CmYnENB60W https://t.co/Qm5hR1fCx6
Links:
Dr. John Cush RheumNow ( View Tweet)
Neutrophil-to-lymphocyte ratio (NLR) was studied in 205 Idiopathic pulmonary fibrosis (IPF) pts - NLR correlated with lung function, & outcomes - NLR >= 2.9 was associated with a significant 2 fold increased risk of mortality https://t.co/FwnfrVW29M https://t.co/BIX8e3svJB
Links:
Dr. John Cush RheumNow ( View Tweet)
Hosp study of 2809 admissions, found 1+adverse events (AE) in 24%. Among 978 AE, 23% (222) were preventable; 32% (316) serious. Preventable AE occurred in 1/15 admissions (serious 1/100). Drug AE were most common (39%) https://t.co/YKaYgmRbLN
Links:
Dr. John Cush RheumNow ( View Tweet)
Join us on 3/18 and 3/19 in Dallas, Texas or virtually for RheumNow Live!
RheumNow Live is unlike any meeting you've ever attended. Here's why:
-Inspired Education
-The Audience Matters
-Never Seen Before
https://t.co/qKoBckRNK1 https://t.co/2tyLsxV0L7
Links:
Dr. John Cush RheumNow ( View Tweet)
Bimekizumab in Active Psoriatic Arthritis - BE COMPLETE study
https://t.co/S4V3rf4cDc https://t.co/XyZMp1CrsX
Links:
Dr. John Cush RheumNow ( View Tweet)
473 RA pts from the BeSt study were analyzed. for correlation betw joint
cumulative inflammation and radiographic damage. Cumulative jt swelling was signif correlated w/ future xray damage/erosions, less so for tender only jts https://t.co/DQ06VYBDxm https://t.co/PfRWCcti8T
Links:
Dr. John Cush RheumNow ( View Tweet)
Case crossover study of 508 #RA pts starting biologics (75% on steroids) showed significantly higher rates of RA flares if steroid doses taken down ≤2.5 mg/d (vs >2.5 mg/d) - adj OR of 1.37 to 1.45 https://t.co/sjkw6LJI0W https://t.co/k0jgnui5CH
Links:
Dr. John Cush RheumNow ( View Tweet)
Degeneration seen in #OA may be related to cartilage tissue stiffening with the repression of a key longevity protein α-Klotho brought about by epigenetic changes. Downregulated Klotho gene expression accelerated chondrocyte senescence https://t.co/HBLeLIlmJG https://t.co/T7d6EodDYN
Dr. John Cush RheumNow ( View Tweet)
ACR GCA classification criteria tested in 676 patients suspected GCA (+US) - 276 dx w/ GCA; 400 not. Sensitivity was 87%, specificity 70%; 35 (13%) GCA pts did not meet criteria. & 119 non-GCA (30%) had ≥6 points (most PMR) https://t.co/bTrj83yM7l https://t.co/9iA8LbX6vB
Links:
Dr. John Cush RheumNow ( View Tweet)